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Supplementary Fig. 1. Fabrication process of the laser-enabled patch. 
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Supplementary Fig. 2. Vector and raster modes of the laser cutting process. a, A CO2 laser 
cutting machine. b, Optical image of laser-scribed graphene patterns via vector mode and raster 
mode, respectively. Scale bar, 1 cm. c,d, SEM images of vector mode-scribed graphene structure. 
Scale bars represent 5 µm (c) and 2 µm (d), respectively. e,f, SEM images of raster mode-scribed 
graphene structure. Scale bars represent 5 µm (e) and 2 µm (f), respectively. 
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Supplementary Fig. 3. Microscopic images showing the resolution of the laser engraving. a–
d, a graphene microelectrode fabricated by the raster mode (a), a graphene micropattern fabricated 
by vector mode (b), and a microfluidic channel fabricated by vector mode under top view (c) and 
cross-sectional view (d). Scale bars, 100 µm.  
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Supplementary Fig. 4. Low-cost and mass-production of the flexible multimodal sensor 
arrays. Scale bar, 1 cm. 
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Supplementary Fig. 5. Characterization of the LEG-based chemical, temperature, and strain 
sensors using Raman spectroscopy. Three experiments were performed independently with 
similar results. 
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Supplementary Fig. 6. Characterization of the LEG-based chemical, temperature, and strain 
sensors using X-ray photoelectron spectroscopy (XPS). Three experiments were performed 
independently with similar results. 
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Supplementary Fig. 7. Circuit diagram of the multiplexed sensing system. a, An FPCB next 
to a quarter dollar coin. b, Circuit diagram of the voltage dividers for driving physical sensor 
measurements. c, Circuit diagram of analog front-end potentiostat for voltammetric sensing. VR 
and VW correspond to the reference potential and the working potential, respectively.  
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Supplementary Fig. 8. Optimization of the LEG-based chemical sensor under different laser 
parameters. Condition, 50 µM UA and 50 µM Tyr. Five experiments were performed 
independently with similar results. 
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Supplementary Fig. 9. Electrochemical impedance spectroscopy (EIS) for LEG-based 
electrodes prepared with different laser-engraving parameters. EIS tests were performed in a 
solution containing 0.2 M KCl and 5 mM [Fe(CN)6]3- at open circuit potentials with an AC 
amplitude of 5 mV in the range of 0.1–1000000 Hz. All conditions were tested for once at the 
same time. 
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Supplementary Fig. 10. Reproducibility of the LEG-based chemical sensors for Tyr and UA 
sensing. a, Continuous successive detection of UA and Tyr using an LEG-CS for 16 cycles. I and 
I0 represent the peak amplitudes of the DPV plot obtained from a give scan cycle and the first cycle, 
respectively. b, Batch to batch variation of the LEG-based chemical sensor performance (10 
batches). I and I0 represent the peak amplitude of the DPV plot, and the average peak amplitude 
obtained from the first batch, respectively. Measure of the centre is the mean value of each batch. 
Error bars represent the standard deviations of the peak amplitudes measured from 16 sensors. 
Conditions: 50 and 100 µM of UA and Tyr.  
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Supplementary Fig. 11. The selectivity of the LEG-CS to UA over other analytes in human 
sweat. I and I0 represent the peak amplitude of the DPV plot of an LEG-CS, and the average peak 
amplitude obtained from the initial UA solution, respectively. The concentrations of the initial UA 
and other analytes are based on Supplementary Table 2. UA concentration was increased by 50% 
in the end. Error bars represent the standard deviations of 4 independent measurements; measure 
of the centre is the mean of the 4 independent measurements. 
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Supplementary Fig. 12. The selectivity of the LEG-CS to Tyr over other analytes in human 
sweat. I and I0 represent the peak amplitude of the DPV plot of an LEG-CS, and the average peak 
amplitude obtained from the initial Tyr solution, respectively. The concentrations of the initial Tyr 
and other analytes are based on Supplementary Table 2. Tyr concentration was increased by 50% 
in the end. Error bars represent the standard deviations of four measurements. Error bars represent 
the standard deviations of 4 independent measurements; measure of the centre is the mean of the 
4 independent measurements. 
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Supplementary Fig. 13. The selectivity of the LEG-CS to Tyr over tryptophan. The DPV plots 
were obtained from solutions containing physiologically relevant levels of Tyr (170 µM) and 
tryptophan (20, 40 and 60 µM). The experiment was repeated 5 times independently with similar 
results.  
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Supplementary Fig. 14. The dependence of sensor response on the solution pH levels. a,b, The 
DPV responses (a) and the corresponding peak amplitudes (b) of the LEG-based chemical 
sensors (3 mm in diameter) for UA sensing in solutions with different pHs. c,d, The DPV 
responses (c) and the corresponding peak amplitudes (d) of the LEG-based chemical sensors for 
Tyr sensing in solutions with different pHs. To prepare the artificial sweat samples with different 
pH, lactic acid was used to adjust the pH of the PBS buffer (0.3X) solutions to physiologically 
relevant pHs. The UA and Tyr concentrations are 100 and 100 µM, respectively. Throughout the 
figure, five independent experiments were performed with similar results, and the mean values 
were taken as measure of the centre. Error bars represent the standard deviations of measurements 
from 5 sensors. 
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Supplementary Fig. 15. The selectivity of the LEG-CS to lactate. Physiologically relevant 
levels of lactic acid (10, 20, 30, and 40 mM) were added to 0.1 M ABS (pH 4.6) containing 50 µM 
UA and 50 µM Tyr. The experiment was repeated 5 times independently with similar results. 
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Supplementary Fig. 16. Characterization and calibration of LEG-CS using the FPCB. a,b, 
DPV curves in ABS solutions containing varied UA concentrations (a) their corresponding 
calibration curve (b). c,d, DPV curves of Tyr in ABS solutions containing varied Tyr 
concentrations (c) and their corresponding calibration curve (d). The experiment was repeated 5 
times independently with similar results. 
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Supplementary Fig. 17. Control of the DPV scan cycle lengths by varying the scan steps. 
Varied incremental potentials (4, 8, and 16 mV) were used to achieve the scan cycle lengths of 90, 
45, 23 seconds. Conditions, 50 µM UA and 250 µM Tyr. The experiment was repeated 5 times 
independently with similar results. 
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Supplementary Fig. 18. Sensor performance for detection of ultra-low levels of other 
electroactive compounds. a,b, the LEG electrodes show excellent sensitivity to AA (40, 80, and 
120 µM) (a) and DA (0.5, 1, and 2 µM) (b). A commercial Ag/AgCl was used as the reference 
electrode. The experiment was repeated 5 times independently with similar results. 
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Supplementary Fig. 19. Stability of the LEG-CS during the bending tests. a,b, The long term 
stability of an LEG-based sensor during the bending test. 0–0.25 % strains were applied for both 
x (a) and y (b) axis. I and I0 represent the current amplitude of the DPV plot during the bending, 
and the average current amplitude without bending, respectively. The error bars represent the 
standard deviation of 10 measurements, the mean of the 10 measurements is measure of the centre. 
Conditions, 50 µM UA and 100 µM Tyr.  
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Supplementary Fig. 20. Porous fiber-like graphene structure for strain sensing. a, Cross-
section SEM image of the fiber-like LEG. Scale bar, 100 µm. b, Magnified view of the fiber-like 
LEG structure. Scale bar, 10 µm. 
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Supplementary Fig. 21. Characterization of the LEG-based temperature sensors. a, Batch to 
batch variation of the LEG-based temperature sensor performance (10 batches). Error bars 
represent the standard deviations of 10 measurements from a temperature sensor; the mean of the 
10 measurements is measure of the centre. b, The response of an LEG-based temperature sensor 
to small temperature changes. The experiment was repeated 5 times independently with similar 
results.
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Supplementary Fig. 22. Batch to batch variation of the LEG-based strain sensors prepared 
with varied laser scanning speeds. Error bars represent the standard deviations of 10 
measurements from a strain sensor under 0.25% strain; the mean of the 10 measurements is the 
center of measure.
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Supplementary Fig. 23.  Heart rate (HR) monitoring using an LEG-based strain sensor. a,b, 
The resistive response of an LEG-based strain sensor (a) and extracted heart rate information (b) 
during long term continuous pulse monitoring on a healthy subject. c,d, The resistive responses of 
the LEG-based strain sensor at 1–3 minutes and at 15–17 minutes during this test. 
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Supplementary Fig. 24.  On-body sensor validation using an FDA-approved vital sign 
monitor during one session. a, Validation of an LEG-PS for heart rate monitoring using an 
FDA-approved heart rate monitor. b, Validation of an LEG-PS for respiration rate monitoring 
using an FDA-approved respiration rate monitor.  
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Supplementary Fig. 25. The long term stability of the LEG-based strain sensor over one 
bending session. a, The measurement was performed during a bending test of a strain sensor 
(10,000 cycles with strains alternated between 0% and 0.1%). b,c, The resistive sensor response 
during 910–915 cycles (b) and 9610–9615 cycles (c) of bending.  
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Supplementary Fig. 26. Characterization and calibration of the temperature and strain 
sensors using the FPCB. a, Calibration curve for the temperature sensor. b,c, Characterization in 
response to pulsed strains (b) and the calibration plot of the strain sensor (c). Throughout the figure, 
the experiments were repeated 3 times independently and similar results were obtained. 
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Supplementary Fig. 27. The numerical simulation showing the fluidic dynamics in the 
reservoir of the lab-on-skin sensor patch. The dimension used here are based on actual sensor 
design used in this work. Scale bar, 5 mm. 
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Supplementary Fig. 28. Inferred sweat rates from different locations of eight healthy subjects 
obtained via optical image analysis. Sub., subject.  
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Supplementary Fig. 29. Characterization of the dynamics of the continuous microfluidic 
sensing. a, Stable peak amplitudes of twelve successive DPV scans in a solution containing 80 
µM UA and 200 µM Tyr with a fixed flow rate of 1 µL min-1. b, Dynamic DPV response of the 
microfluidic sensing when the inflow solution was switched from 20 µM UA and 50 µM Tyr to 
80 µM UA and 200 µM Tyr with a fixed flow rate of 1 µL min-1. A DPV scan was performed 
every minute (with a scan step of 8 mV and a scan cycle of 45 seconds). Throughout the figure, 
the experiments were repeated 3 times independently and similar results were obtained. 
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Supplementary Fig. 30. Characterization of continuous microfluidic sensing performance 
under different flow rates. a, The DPV plots of an LEG-CS for UA and Tyr sensing at different 
flow rates (from 0.25 to 1.5 µL min-1). b, The peak amplitudes of UA and Tyr in 5 successive 
DPV scans (2.5 minutes per scan with a 45-s scan cycle length) with different flow rates (from 
0.25 to 1.5 µL min-1). Conditions, 80 µM UA and 200 µM Tyr. Throughout the figure, the 
experiments were repeated 3 times independently and similar results were obtained. 
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Supplementary Fig. 31. The DPV plots obtained by the sensor patch from a healthy subject’s 
neck during the cycling exercise, in one biking session. Conditions, same as Fig. 5b.  
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Supplementary Fig. 32. Data processing of the strain sensor involving data filtering and fast 
Fourier transform (FFT) to obtain the heart rate (HR) and respiration rate (RR) values. a–
c, An example of the raw data (a), filtered data (b), and FFT extracted frequency data (c) toward 
RR monitoring. The raw data was collected by a strain sensor from a healthy subject. d–f, An 
example of the raw data (d), filtered data (e), and FFT extracted frequency data (f) toward HR 
monitoring. HR and RR values were obtained from the frequencies that had highest intensity in 
the given periods. The raw data was collected by a strain sensor from a healthy subject.  
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Supplementary Fig. 33. The peak amplitude of DPV curves in Fig. 5c,d obtained during the 
on-body UA and Tyr measurement from the neck (a) and the forehead (b) of a healthy 
subject during one biking session.  
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Supplementary Fig. 34. HPLC analyses of the UA and Tyr in sweat. The experiments were 
repeated 3 times independently and similar results were obtained. 
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Supplementary Fig. 35. Selectivity of HPLC analyses of the UA (a) and Tyr (b) over common 
sweat analytes. The concentrations of the initial UA/Tyr and added other analytes are based on 
Supplementary Table 2. UA and Tyr levels were increased by 50% in the end for a and b, 
respectively. Throughout this figure, the experiments were repeated 3 times independently and 
similar results were obtained. 
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Supplementary Fig. 36. Validation of the accuracy of the LEG-CS for UA (a) and Tyr (b) 
sensing using colorimetric assay kits. The data are based on 28 sweat samples collected from the 
healthy subjects. UA and Tyr concentrations by the sensor were obtained from the sensor reading 
and the linear fitting in Fig. 5e,f. The Pearson correlation coefficient was acquired through linear 
regression. 
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Supplementary Fig. 37. Dynamic Tyr monitoring using the sensor patch after Tyr 
supplementation. The experiment was performed on a healthy subject over one iontophoresis-
induced sweat secretion process. The experiment was repeated twice independently with similar 
results.
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Supplementary Fig. 38. The influence of high and low protein intakes on sweat UA and Tyr. 
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Supplementary Fig. 39. Investigation of the sweat and serum UA levels using a purine-rich 
diet challenge. UA levels in sweat and serum of two heathy subjects under fasting condition, and 
after a purine-rich diet on two different days. Measure of the center in a–d is the mean value of 
the first two successive measurements. 
0
30
60
90
120
 Fasting
 Purine-rich
Subject 3 (male), day 1
Sweat Serum
μ μ
300
400
500
600
700
0
30
60
90
120
 Fasting
 Purine-rich
300
400
500
600
700
Sweat
Subject 3 (male), day 2
Serum
μμ
0
20
40
60
80
 Fasting
 Purine-rich
μ μ
200
300
400
500
Sweat
Subject 4 (male), day 1
Serum
0
20
40
60
80
 Fasting
 Purine-rich
μ μ
200
300
400
500
Sweat
Subject 4 (male), day 2
Serum
dc
ba
Supplementary Fig. 40. HPLC analyses of the sweat (a,b) and serum (c,d) UA levels of a 
healthy subject (a,c) and a patient with gout (b,d). The experiment was repeated 3 times 
independently with similar results.  
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Supplementary Fig. 41. The influence of urate-lowering medication (allopurinol) on the sweat 
and serum UA levels. The sweat and blood tests were performed on the same gout patient on two 
days: on one day the patient received urate-lowering medication 2 hours before the test, and on the 
other day the patient did not take medication 24 hours before the test. The center of measure is the 
mean value of the first two successive measurements from one patient. 
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Supplementary Table 1. Optimization of the LEG-CS with different laser parameters. 
Electrode # UA Peak (mA cm-2) 
Optimization of chemical sensors under different laser parameters
Power (%) Speed (%) PPI Tyr Peak (mA cm-2) 
1
2
3
4
5
6
7
8
9
12
11
10
6.3
6
6
6
6
5.5
6.5
7.5
6
6
6
6
5.5
5
6
7
8
5
5
5
5
5
5
5
1000
1000
1000
1000
1000
1000
1000
1000
250
1000
750
500
0.142
0.003
0.091
0.113
0.05
0
0.132
0.101
0.138
0.131
0.1
0.115
0.061
0
0.035
0.029
0.013
0
0.043
0.032
0.045
0.031
0.033
0.049
 
Supplementary Table 2. Sweat analytes and their concentrations used for the selectivity 
studies. The values were chosen based on the mean physiological levels of the analytes46. 
 
 
  
Constituents
Median values of human sweat constituents
Concentration (μ )
Alanine
Arginine
Ascorbic acid
Aspartic acid
Choline chloride
Citrulline
Creatine
Creatinine
Dehydroascorbic acid
Glycine
Glutamic acid
Folic acid
Histidine
Inositol
Isoleucine
Leucine
Number
1
2
3
4
5
6
7
8
9
12
11
10
13
14
15
16
360
780
10
340
50
400
15
84
11
390
370
50
520
1.6
16
210
Constituents Concentration (μ )Number
Lysine
Methionine
Nicotinic acid
Ornithine
Pantothetic acid
Phenylalanine
Pyridoxine
Riboflavin
Serine
Tryptophan
Threonine
Thiamine
Tyrosine
Uric acid
Valine
17
18
19
20
21
22
23
24
25
28
27
26
29
30
31
150
50
50
150
50
130
0.01
50
50
55
450
50
170
60
250
 
Supplementary Table 3. UA HPLC gradient method. 
 
 
  
Eluent A Time (min)
Uric acid HPLC gradient method
Eluent B Flow rate Percentage eluent B (%)
0.34
mL min-1
0
6
6.2
7.5
7.9
15
0
0
100
100
0
0
Acetonitrile
100%
0.1%
Formic acid
 
Supplementary Table 4. Tyr HPLC gradient method. 
 
 
  
Eluent A Time (min)
Tyrosine HPLC gradient method
Eluent B Flow rate Percentage eluent B (%)
0.425
mL min-1
0
4
8
12
15
20
9.1
9.1
80
80
9.1
9.1
Methanol
100%
50 mM
KH2PO4-H3PO4
buffer
pH 3.0
 
Supplementary Note 1. The selectivity of the LEG-CS for sweat UA and Tyr sensing 
Current wearable electrochemical sweat sensors are primarily focused on a limited number of 
electrolytes (e.g., Na+, K+, Cl-) and metabolites (e.g., lactate and glucose) at high concentrations 
(usually at mM levels) monitored via ion-selective sensors or enzymatic electrodes; biosensors 
based on bioreceptors (e.g., antibodies) could be highly sensitive, but usually require multiple 
washing steps and detection in standard buffer or redox solutions in order to transduce the 
bioaffinity interactions.  
The approach we utilize here for continuous monitoring of UA and Tyr is based on their selective 
oxidation reaction at a specific potential. The selectivity is based on the oxidation peak position 
for the LEG-CS. We evaluate here the selectivity of the LEG-CS over the common amino acids, 
vitamins and other potential interfering chemicals at physiological relevant concentrations in 
human sweat listed in Supplementary Table 2. Our electrochemical sensing data in 
Supplementary Figs. 11 and 12 show that the physiological level sweat analytes have minimal 
influence on the detection of UA and Tyr using the LEG-CS.  
There are few electroactive molecules reported to be present in human sweat with comparable 
concentrations with UA and Tyr. Dopamine is a well-known electroactive neurotransmitter present 
at high concentration in cerebrospinal fluid. Our data in Fig. 2i shows that at the same conditions, 
the dopamine oxidation peak appears at a more negative potential than UA and doesn’t affect the 
UA monitoring. In fact, to our knowledge, there is no literature report on the presence of dopamine 
in human sweat. Another electroactive molecule tryptophan has a close oxidation peak position to 
Tyr. However, tryptophan is present at a much lower concentration compared to Tyr. Our 
selectivity study (Supplementary Fig. 13) shows that physiologically relevant concentrations of 
tryptophan do not significantly affect our Tyr measurement. 
As pH is usually a key factor that could influence electrochemical sweat sensor performance, we 
try to evaluate here the influence of pH on the sensor performance in artificial sweat (with pH 
values adjusted by varying lactic acid as lactic acid is the main contributing factors for sweat pH). 
Considering the normal sweat pH range in the literature and from our human subjects (pH ranges 
from 4 to 6), the dependence of the chemical sensor performance in artificial sweat with pHs 
between 4 to 6 was examined. Our results in Supplementary Fig. 14 show that, although the 
oxidation peak positions slightly shift under different pHs, the peak amplitudes of UA and Tyr 
 
sensing remain stable in the range of pH 4 to pH 6. Considering that we are essentially measuring 
the peak heights, the influence of the pH is small to our sensors. Moreover, it is worth noting that 
the variations of pH values of an individual’s sweat at different time points during biking session 
and at different biking sessions are small. 
To further validate the accuracy and selectivity of the LEG-CS, the sensor readings in human sweat 
samples have been validated with two current gold standards – high performance liquid 
chromatography (HPLC) (Fig. 5e,f and Supplementary Fig. 35) and commercial colorimetric 
assay kits (Supplementary Fig. 36). Very high linear coefficients (0.963 and 0.965 for UA and 
Tyr with HPLC, 0.965 and 0.967 for UA and Tyr with the commercial colorimetric assays) were 
found, revealing the great reliability and accuracy of our sensor technology toward sweat UA and 
Tyr sensing. 
 
